Renaissance Technologies’s LianBio American Depositary Shares LIAN Stock Holding History

Renaissance Technologies’s Portfolio LIAN Stock Details LIAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-346,000	Closed	-$1.55M	–	4196
2023 Q4	$1.55M	Buy	346,000 +63,398	+22%	+$218K	﹤0.01%	2106
2023 Q3	$421K	Sell	282,602 -25,898	-8%	-$49.3K	﹤0.01%	2793
2023 Q2	$703K	Buy	308,500 +12,300	+4%	+$28.3K	﹤0.01%	2694
2023 Q1	$581K	Buy	296,200 +5,578	+2%	+$11.6K	﹤0.01%	2800
2022 Q4	$477K	Sell	290,622 -24,378	-8%	-$38K	﹤0.01%	2973
2022 Q3	$630K	Buy	315,000 +254,100	+417%	+$608K	﹤0.01%	2785
2022 Q2	$132K	Buy	60,900 +24,376	+67%	+$82.8K	﹤0.01%	3774
2022 Q1	$136K	Buy	+36,524	New	+$151K	﹤0.01%	3741

Other funds holding LIAN

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Renaissance Technologies's LIAN Position: Q1 2024 in Review

Renaissance Technologies sold out of LianBio American Depositary Shares (LIAN) in Q1 2024, closing a stake of 346,000 shares — an estimated $1.55M sold.

Renaissance Technologies first reported a position in LIAN in Q1 2022 and held it in 8 quarters. The position peaked at $1.55M in Q4 2023. 3 funds tracked by Wall St. Rank hold LIAN as of Q1 2024.

Renaissance Technologies reported no remaining LianBio American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Renaissance Technologies sold 346,000 LianBio American Depositary Shares shares in Q1 2024, an estimated $1.55M.
Renaissance Technologies first reported a position in LianBio American Depositary Shares in Q1 2022 and held it in 8 quarters.
Renaissance Technologies's LianBio American Depositary Shares position peaked at $1.55M in Q4 2023.
3 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q1 2024.

Based on Renaissance Technologies's 13F filing for Q1 2024, filed 13 May 2024.